Last edition
News about "United States Food and Drug Administration"
Lupin Gets Approval from US FDA for Prednisolone Acetate Ophthalmic Suspension
Lupin has secured approval from US FDA for its Abbreviated New Drug Application (ANDA) for Prednisolone Acetate Ophthalmic Suspension USP, 1 percent to market a generic equivalent of Pred Forte Ophthalmic Suspension, 1 percent, of AbbVie Inc.
United States Food And Drug Administration | 07/08/2024 | By Aishwarya | 118
Gland Pharma Gets Tentative Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution
Gland Pharma Ltd. has secured tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024 percent.
United States Food And Drug Administration | 24/07/2024 | By Aishwarya | 224
ForDoz Secures US FDA Approval for Doxorubicin Hydrochloride Liposome Injection
Lupin has announced that its alliance partner, ForDoz Pharma Corp. has received approval from US FDA for its Abbreviated New Drug Application for Doxorubicin Hydrochloride Liposome Injection, Single-Dose Vials, to market a generic equivalent of Doxil Liposom.
United States Food And Drug Administration | 22/07/2024 | By Aishwarya
FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors
The U.S. Food and Drug Administration today approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors (neutralizing antibodies)
United States Food And Drug Administration | 02/04/2020 | By Darshana | 247
FDA Continues to Accelerate Development of Novel Therapies for COVID-19
As part of the Trump Administration's all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments
United States Food And Drug Administration | 01/04/2020 | By Darshana | 430
Lupin launches Ethacrynic Acid Tablets USP
Pharma major Lupin Limited (Lupin) announced the launch of Ethacrynic Acid Tablets USP, 25 mg, having received approval from the United States Food and Drug Administration (U.S. FDA) earlier. The product would be manufactured at Lupin's Nagpur OSD facility, India
United States Food And Drug Administration | 14/03/2020 | By Darshana | 564
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy